SCHEMBL4944659

SCHEMBL4944659

COc1ccc(C2=NN(c3cccc(C(=O)N4CCOCC4)c3)C(=O)C(C)(C)C2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
NPC1 O15118 1/20 0.48
KMT2A Q03164 5/20 0.48
MEN1 O00255 3/20 0.48
RAB9A P51151 1/20 0.48
POLB P06746 2/20 0.48
PKM P14618 1/20 0.48
HPGD P15428 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
ERN1 O75460 1/20 0.47
GLA P06280 1/20 0.46
MAPK1 P28482 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PRKCZ Q05513 1/20 0.44
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4937607 0.91 MAPT (0.54) MAPTNPC1KMT2AMEN1POLB
SCHEMBL4943052 0.85 PDE4B (0.53) MAPTNPC1KMT2AMEN1RAB9A
Hydrochloric Acid SCHEMBL4945220 0.84 TLR9 (0.51) MAPTNPC1KMT2AMEN1POLB
SCHEMBL4942500 0.83 MAPT (0.48) MAPTNPC1KMT2AMEN1RAB9A
SCHEMBL4943065 0.82 HTT (0.57) MAPTNPC1KMT2AMEN1PKM
SCHEMBL4943419 0.81 TP53 (0.55) MAPTNPC1RAB9APOLBHPGD
Hydrochloric Acid SCHEMBL4937621 0.78 GAA (0.49) MAPTNPC1ALDH1A1GAASMN1; SMN2
SCHEMBL4944690 0.77 PDE5A (0.53) KMT2AMEN1ALDH1A1PDE4APDE4B
SCHEMBL4945670 0.77 PDE4B (0.51) PDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL4941529 0.75 F10 (0.47) NPC1KMT2AMEN1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors ALTANA PHARMA AG (DE) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227790-A1 Pyridazinone Derivatives and their Use as Pde4 Inhibitors PDE4A, PDE4B, PDE5A MAPT 4017/4885NPC1 4383/4885KMT2A 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.